Results for tag: "Leukotriene"

The Leukotriene market is a subset of the larger Respiratory Drugs market. Leukotrienes are a type of lipid mediator that are involved in the inflammatory response of the body. They are produced by cells in the body in response to allergens, irritants, and other stimuli. Leukotriene inhibitors are used to treat asthma, allergies, and other respiratory conditions. These drugs work by blocking the action of leukotrienes, thus reducing inflammation and improving symptoms. Leukotriene inhibitors are available in both oral and inhaled forms. Inhaled forms are typically used for the treatment of asthma, while oral forms are used for the treatment of allergies. The market for Leukotriene inhibitors is growing, as more people are being diagnosed with respiratory conditions. Some companies in the Leukotriene market include GlaxoSmithKline, Merck, AstraZeneca, and Novartis. These companies produce a variety of Leukotriene inhibitors, including Singulair, Accolate, and Zyflo. Show Less Read more